Reuters logo
BRIEF-Stemline Therapeutics Q2 loss per share $0.66
August 8, 2017 / 11:20 AM / 3 months ago

BRIEF-Stemline Therapeutics Q2 loss per share $0.66

Aug 8 (Reuters) - Stemline Therapeutics Inc

* Stemline Therapeutics reports second quarter 2017 financial results

* Q2 loss per share $0.66

* Q2 earnings per share view $-0.48 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below